23 February 2022>: Clinical Research
A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy Under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire
Di Lu 1ABCDEFG* , Chun Shan Bi 2ABCE* , Xue Wei 1BCDEF* , Bao Na Guo 2BC , Ying Xin Gao 1BG , Jing Chen 2B , Jie Qian 1BG , Zi Hao Guo 2B , Yan Bin Wang 1B , Li Li 2B , Chuan Zhang 2A* , Jian Yu Hao 1AG* , Yan Gao 1ABD*DOI: 10.12659/MSM.933848
Med Sci Monit 2022; 28:e933848
Table 2 Comparison of GerdQ* score between the 2 groups.
Timing of RF** | Direct vision (N=27) | Non-direct vision (N=29) | P value |
---|---|---|---|
Before RF** | 11.0 (10.0, 12.0) | 10.0 (8.5, 11.5) | 0.076 |
3 months after RF** | 6.0 (6.0, 8.0) | 8.0 (7.0, 9.0) | 0.026 |
6 months after RF** | 7.0 (6.0, 8.0) | 8.0 (7.0, 9.0) | 0.023 |
12 months after RF (N=45)** | 8.0 (7.0, 8.0) (N=21) | 8.5 (8.0, 9.8) (N=24) | 0.008 |
* GerdQ denotes gastroesophageal reflux disease questionnaire; ** RF denotes radiofrequency. |